It was verified through a knockout experiment that A22 reduced renal tubular epithelial cell apoptosis by stabilizing the BCL-2 gene promoter i-motif, resulting in up-regulation of the anti-apoptotic factor BCL-2 in the AKI model. The gene discussed is BCL2; the disease is acute kidney injury.